Safety and efficacy of plerixafor dose escalation for the mobilization of CD34+ hematopoietic progenitor cells in patients with sickle cell disease: interim results. uri icon

Overview

publication date

  • September 1, 2018

Identity

PubMed Central ID

  • PMC6119146

Scopus Document Identifier

  • 85052907102

Digital Object Identifier (DOI)

  • 10.3324/haematol.2018.199414

PubMed ID

  • 30171018

Additional Document Info

volume

  • 103

issue

  • 9